Literature DB >> 16239840

Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease.

Richard K Russell1, Hazel E Drummond, Elaine E Nimmo, Niall Anderson, Linda Smith, David C Wilson, Peter M Gillett, Paraic McGrogan, Kamal Hassan, Lawrence T Weaver, Michael Bisset, Gamal Mahdi, Jack Satsangi.   

Abstract

INTRODUCTION: The incidence of early-onset CD in Scotland is among the highest worldwide. Three single nucleotide polymorphisms (SNPs) R702W, G908R and Leu1007finsC in the NOD2/CARD15 gene predispose to adult CD. We investigated the contribution of these variants to disease susceptibility and phenotype in the Scottish early-onset IBD population. PATIENTS AND METHODS: 906 individuals including 247 Scottish IBD patients aged <16 years at diagnosis, 414 parents and 245 controls were genotyped. Transmission disequilibrium testing (TDT), case-control analysis and detailed genotype-phenotype analysis were performed.
RESULTS: The Leu1007finsC variant was associated with susceptibility to CD by case-control (4.2% versus. 1.4%, P = 0.01) and TDT analysis (P = 0.006). The Population Attributable Risk (PAR) for the 3 NOD2/CARD15 mutations was 7.9%. Carriage of NOD2/CARD15 variants was associated with, at diagnosis: decreased albumin (31.0% versus. 9.0%, P = 0.001) and raised CRP (25% versus. 9.5%, P = 0.04) and at follow up: need for surgery (39.5% versus. 12.8%, P = 0.0002) jejunal involvement (50% versus. 18.4%, P = 0.01) jejunal and ileal involvement (50% versus. 10.7%, P = 0.009), raised CRP (57.1% and 12.8%, P = 0.0009), lower weight/height centile (75.0% versus. 20.2%, P = 0.03, 50.0% versus. 16.0%, P = 0.001 respectively) and stricturing disease (45.5% versus. 19.4%, P < 0.05). Multifactorial analysis demonstrated carriage was associated with need for surgery (P = 0.004, OR 4.9 [1.5-14.7]).
CONCLUSIONS: These NOD2/CARD 15 variants in the Scottish early onset CD population have a definite, albeit relatively small contribution to CD susceptibility (PAR 7.9%) but a major impact on phenotype. In particular NOD2/CARD15 variants are strongly associated with several markers of disease severity in pediatric CD, notably need for surgery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239840     DOI: 10.1097/01.mib.0000183423.38037.f3

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  29 in total

1.  IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland.

Authors:  J Van Limbergen; R K Russell; E R Nimmo; H E Drummond; L Smith; G Davies; N H Anderson; P M Gillett; P McGrogan; K Hassan; L Weaver; W M Bisset; G Mahdi; D C Wilson; J Satsangi
Journal:  Gut       Date:  2007-03-02       Impact factor: 23.059

Review 2.  The future of molecular approaches to inflammatory bowel disease.

Authors:  Boyko Kabakchiev; Smita Halder; Mark S Silverberg
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 3.  Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis.

Authors:  Charles L Bevins; Nita H Salzman
Journal:  Nat Rev Microbiol       Date:  2011-03-22       Impact factor: 60.633

4.  NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.

Authors:  Maria Gazouli; Ioanna Pachoula; Ioanna Panayotou; Gerassimos Mantzaris; George Chrousos; Nicholas P Anagnou; Eleftheria Roma-Giannikou
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

Review 5.  Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis.

Authors:  Saleh A Naser; Melissa Arce; Anam Khaja; Marlene Fernandez; Najih Naser; Sammer Elwasila; Saisathya Thanigachalam
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

6.  African-American inflammatory bowel disease in a Southern U.S. health center.

Authors:  Hemanth Veluswamy; Kunal Suryawala; Ankur Sheth; Shannon Wells; Erik Salvatierra; Walter Cromer; Ganta V Chaitanya; Annette Painter; Mihir Patel; Kenneth Manas; Ellenmarie Zwank; Moheb Boktor; Kondal Baig; Balaji Datti; Michael J Mathis; Alireza Minagar; Paul A Jordan; Jonathan S Alexander
Journal:  BMC Gastroenterol       Date:  2010-09-09       Impact factor: 3.067

7.  Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases.

Authors:  S Cucchiara; A Latiano; O Palmieri; A M Staiano; R D'Incà; G Guariso; G Vieni; V Rutigliano; O Borrelli; M R Valvano; V Annese
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

Review 8.  Mechanisms of growth impairment in pediatric Crohn's disease.

Authors:  Thomas D Walters; Anne M Griffiths
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09       Impact factor: 46.802

Review 9.  The role of the innate and adaptive immune system in pediatric inflammatory bowel disease.

Authors:  Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

10.  Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease.

Authors:  Hilbert S de Vries; Theo S Plantinga; J Han van Krieken; Rinke Stienstra; Ad A van Bodegraven; Eleonora A M Festen; Rinse K Weersma; J Bart A Crusius; Ronald K Linskens; Leo A B Joosten; Mihai G Netea; Dirk J de Jong
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.